Incivo European Union - English - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatitis c, chronic - antivirals for systemic use - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype-1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis):who are treatment naïve;who have previously been treated with interferon alfa (pegylated or non-pegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.

Memantine ratiopharm European Union - English - EMA (European Medicines Agency)

memantine ratiopharm

ratiopharm gmbh - memantine hydrochloride - alzheimer disease - psychoanaleptics, - treatment of patients with moderate to severe alzheimer’s disease

Olysio European Union - English - EMA (European Medicines Agency)

olysio

janssen-cilag international nv - simeprevir - hepatitis c, chronic - antivirals for systemic use - olysio is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult patients.for hepatitis c virus (hcv) genotype specific activity.

Evra transdermal patches United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

evra transdermal patches

janssen-cilag ltd - norelgestromin; ethinylestradiol - transdermal patch - 203microgram/24hour ; 33.9microgram/24hour

Vokanamet 50mg850mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vokanamet 50mg850mg tablets

napp pharmaceuticals ltd - canagliflozin hemihydrate; metformin hydrochloride - tablet - 50mg ; 850mg

Vokanamet 50mg1000mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vokanamet 50mg1000mg tablets

napp pharmaceuticals ltd - canagliflozin hemihydrate; metformin hydrochloride - tablet - 50mg ; 1gram